跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,604 条关于
“transthyretin-associated amyloidosis”
全部
21,604
临床试验
10,579
药物
405
机构
107
资讯
10,513
去年
EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
3个月前
Attralus' Zamubafusp Alfa Receives FDA Orphan Drug Designation for AL Amyloidosis
去年
Swissmedic Authorizes Tegsedi for Hereditary Transthyretin Amyloidosis
去年
OHSU Tests CRISPR Gene Editing for Transthyretin Amyloidosis in Clinical Trial
去年
Eplontersen (Wainzua) Recommended in England and Wales for Hereditary Transthyretin Amyloidosis
去年
FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
FDA Grants Orphan Drug Designation to COAGADEX for Rare Bleeding Disorder Associated with AL Amyloidosis
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
FDA Accepts Alnylam's Vutrisiran sNDA for ATTR Amyloidosis with Cardiomyopathy
第 1 页，共 1052 页
上一页
下一页
